УСКОРЕННЫЕ РЕЖИМЫ АДЪЮВАНТНОЙ ЛУЧЕВОЙ ТЕРАПИИ В ЛЕЧЕНИИ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
Аннотация
Об авторах
Г. В. АфонинРоссия
аспирант, врач-онколог отделения лучевого и хирургического лечения заболеваний торакальной области,
249031, Калужская область, Обнинск, ул. Маршала Жукова, д. 10
Ю. А. Рагулин
Россия
к.м.н., заведующий отделением лучевого и хирургического лечения заболеваний торакальной области,
249031, Калужская область, Обнинск, ул. Маршала Жукова, д. 10
И. А. Гулидов
Россия
д.м.н., профессор, заведующий отделом лучевой терапии
Список литературы
1. Каприн А.Д., Старинский В.В., Петрова Г. В. Состояние онкологической помощи населению России в 2015 году.М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2016, с. 5, 31, 198.
2. McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10‑year recurrence and 20‑year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014 Jun 21; 383 (9935): 2127–35. DOI: 10.1016/S0140–6736 (14)60488–8. Epub 2014 Mar 19.
3. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10‑year recurrence and 15‑year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011 Nov 12; 378 (9804): 1707–16. DOI: 10.1016/S0140–6736 (11)61629–2
4. Mortimer JW, McLachlan CS, Hansen CJ, Assareh H, Last A, McKay MJ, et al. Use of hypofractionated post-mastectomy radiotherapy reduces health costs by over $2000 per patient: An Australian perspective. J Med Imaging Radiat Oncol. 2016 Feb; 60 (1): 146–53. DOI: 10.1111/1754–9485.12405
5. Rudat V, Nour A, Hammoud M, et al. Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy. Strahlenther Onkol. 2017; 193 (5): 375–384. DOI: 10.1007/s00066–017–1115‑z
6. Bese NS, Sut PA, Ober A. The effect of treatment interruptions in the postoperative irradiation of breast cancer. Oncology. 2005; 69 (3): 214–23. DOI: 10.1159/000087909
7. Smith BD, Bentzen SM, Correa CR, Hahn CA, Hardenbergh PH, Ibbott GS, et al. Fractionation for whole breast irradiation: an American Society For Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81 (1):59–68. DOI: 10.1016/j.ijrobp.2010.04.042
8. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010 Feb 11; 362 (6): 513–20. DOI: 10.1056/NEJMoa0906260.
9. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006 Jun; 7 (6): 467–71. DOI: 10.1016/S1470–2045 (06)70699–4
10. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et.al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10‑year follow-up results of two randomised controlled trials. Lancet Oncol. 2013 Oct; 14 (11): 1086–94. DOI: 10.1016/S1470–2045 (13)70386–3
11. Haviland JS, Bentzen SM, Bliss JM, Yarnold JR, START Trial Management Group. Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation. Radiother Oncol. 2016 Dec; 121 (3): 420–423. DOI: 10.1016/j.radonc.2016.08.027
12. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, et al. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol. 2015 Oct; 1 (7): 931–41. DOI: 10.1001/jamaoncol.2015.2666
13. Koukourakis MI, Tsoutsou PG, Abatzoglou IM, Sismanidou K, Giatromanolaki A, Sivridis E. Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74 (4): 1173–80. DOI: 10.1016/j.ijrobp.2008.09.016
14. Karasawa K, Kunogi H, Hirai T, Hojo H, Hirowatari H, Izawa H, et al. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients. Breast Cancer. 2014 Jul; 21 (4): 402–8. DOI: 10.1007/s12282–012–0406–6
15. Linares I, Tovar MI, Zurita M, Guerrero R, Expósito M, Del Moral R. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity. Clin Breast Cancer. 2016 Aug; 16 (4): 262–8. DOI: 10.1016/j.clbc.2015.09.012
16. Jagsi R, Griffith KA, Boike TP, Walker E, Nurushev T, Grills IS, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule. Comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol. 2015 Oct;1 (7):918–30. DOI: 10.1001/jamaoncol.2015.2590
17. Гладилина И.А., Клеппер Л.Я., Ефимкина Ю.В., Высоцкая И.В., Петровский А.В., Козлов О.В., и др. Гипофракционированный ускоренный режим лучевой терапии у больных после органосохраняющих операций по поводу I–IIА стадий рака молочной железы. Опухоли женской репродуктивной системы. 2016; 12 (3): 17–22. DOI: 10.17650/1994–4098–2016–12–3-17–22
18. Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med. 2015 Jul 23;373 (4):317–27. DOI: 10.1056/NEJMoa1415369
19. Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015 Jul 23; 373 (4): 307–16. DOI: 10.1056/NEJMoa1415340
20. NCCN Guidelines Version 1.2017 03/10/17, 96–99.
21. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015 Sep;26 Suppl 5: v8–30. DOI: 10.1093/annonc/mdv298
22. Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys. 2000 Jul 15;47 (5): 1219–28. DOI: 10.1016/S0360–3016 (00)00567–8
23. Каприн А.Д., Галкин В.Н., Жаворонков Л.П., Иванов В.К., Иванов С.А., Романко Ю. С. Синтез фундаментальных и прикладных исследований — основа обеспечения высокого уровня научных результатов и внедрения их в медицинскую практику. Радиация и риск. 2017; 26 (2): 26–40.
Для цитирования:
Афонин Г.В., Рагулин Ю.А., Гулидов И.А. УСКОРЕННЫЕ РЕЖИМЫ АДЪЮВАНТНОЙ ЛУЧЕВОЙ ТЕРАПИИ В ЛЕЧЕНИИ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ. Research'n Practical Medicine Journal. 2017;4(3):66-74. https://doi.org/10.17709/2409-2231-2017-4-3-6
For citation:
Afonin G.V., Ragulin Yu.A., Gulidov I.A. ACCELERATED REGIMENS OF ADJUVANT RADIOTHERAPY IN THE TREATMENT OF BREAST CANCER. Research and Practical Medicine Journal. 2017;4(3):66-74. (In Russ.) https://doi.org/10.17709/2409-2231-2017-4-3-6